BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22018935)

  • 1. A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.
    Hébert JR; Hurley TG; Harmon BE; Heiney S; Hebert CJ; Steck SE
    Cancer Epidemiol; 2012 Apr; 36(2):e128-36. PubMed ID: 22018935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer.
    Antwi SO; Steck SE; Zhang H; Stumm L; Zhang J; Hurley TG; Hebert JR
    Cancer Epidemiol; 2015 Oct; 39(5):752-62. PubMed ID: 26165176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer?
    Saxe GA; Hébert JR; Carmody JF; Kabat-Zinn J; Rosenzweig PH; Jarzobski D; Reed GW; Blute RD
    J Urol; 2001 Dec; 166(6):2202-7. PubMed ID: 11696736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary manipulation, ethnicity, and serum PSA levels.
    Eastham JA; Riedel E; Latkany L; Fleisher M; Schatzkin A; Lanza E; Shike M;
    Urology; 2003 Oct; 62(4):677-82. PubMed ID: 14550442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial.
    Shike M; Latkany L; Riedel E; Fleisher M; Schatzkin A; Lanza E; Corle D; Begg CB
    J Clin Oncol; 2002 Sep; 20(17):3592-8. PubMed ID: 12202659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.
    van Die MD; Williams SG; Emery J; Bone KM; Taylor JM; Lusk E; Pirotta MV
    Prostate; 2017 May; 77(7):765-775. PubMed ID: 28181675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dietary intervention for recurrent prostate cancer after definitive primary treatment: results of a randomized pilot trial.
    Carmody J; Olendzki B; Reed G; Andersen V; Rosenzweig P
    Urology; 2008 Dec; 72(6):1324-8. PubMed ID: 18400281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators to healthy lifestyle and acceptability of a dietary and physical activity intervention among African Caribbean prostate cancer survivors in the UK: a qualitative study.
    Er V; Lane JA; Martin RM; Persad R; Chinegwundoh F; Njoku V; Sutton E
    BMJ Open; 2017 Oct; 7(10):e017217. PubMed ID: 29038181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
    Duchesne GM; Woo HH; Bassett JK; Bowe SJ; D'Este C; Frydenberg M; King M; Ledwich L; Loblaw A; Malone S; Millar J; Milne R; Smith RG; Spry N; Stockler M; Syme RA; Tai KH; Turner S
    Lancet Oncol; 2016 Jun; 17(6):727-737. PubMed ID: 27155740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction.
    Saxe GA; Major JM; Nguyen JY; Freeman KM; Downs TM; Salem CE
    Integr Cancer Ther; 2006 Sep; 5(3):206-13. PubMed ID: 16880425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy.
    Wojno KJ; Vashi AR; Schellhammer PF; Wright GL; Montie JE
    Urology; 1998 Sep; 52(3):474-8. PubMed ID: 9730464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy.
    Lin AM; Rini BI; Weinberg V; Fong K; Ryan CJ; Rosenberg JE; Fong L; Small EJ
    BJU Int; 2006 Oct; 98(4):763-9. PubMed ID: 16796694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of a plant-based diet by patients with recurrent prostate cancer.
    Nguyen JY; Major JM; Knott CJ; Freeman KM; Downs TM; Saxe GA
    Integr Cancer Ther; 2006 Sep; 5(3):214-23. PubMed ID: 16880426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of
    Meredith G; Wong D; Yaxley J; Coughlin G; Thompson L; Kua B; Gianduzzo T
    BJU Int; 2016 Oct; 118 Suppl 3():49-55. PubMed ID: 27659411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein.
    Bosland MC; Kato I; Melamed J; Taneja S; Lepor H; Torre P; Walden P; Zeleniuch-Jacquotte A; Lumey LH
    Urology; 2001 Apr; 57(4 Suppl 1):202-4. PubMed ID: 11295628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.
    Spetsieris N; Boukovala M; Alafis I; Davis J; Zurita A; Wang X; Tu SM; Chapin BF; Aparicio A; Corn P; Wang J; Subudhi SK; Araujo J; Papadopoulos J; Pruitt L; Weldon JA; Logothetis CJ; Efstathiou E
    Eur J Cancer; 2021 Nov; 157():259-267. PubMed ID: 34536949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy.
    Sartor CI; Strawderman MH; Lin XH; Kish KE; McLaughlin PW; Sandler HM
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):941-7. PubMed ID: 9276358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
    Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
    Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.